Literature DB >> 23559631

Loss of function of parathyroid hormone receptor 1 induces Notch-dependent aortic defects during zebrafish vascular development.

Caroline Gray1, David Bratt, Julie Lees, Marc daCosta, Karen Plant, Oliver J Watson, Sara Solaymani-Kohal, Simon Tazzyman, Jovana Serbanovic-Canic, David C Crossman, Bernard D Keavney, Andrea Haase, Kathryn McMahon, Martin Gering, Henry Roehl, Paul C Evans, Timothy J A Chico.   

Abstract

OBJECTIVE: Coarctation of the aorta is rarely associated with known gene defects. Blomstrand chondrodysplasia, caused by mutations in the parathyroid hormone receptor 1 (PTHR1) is associated with coarctation of the aorta in some cases, although it is unclear whether PTHR1 deficiency causes coarctation of the aorta directly. The zebrafish allows the study of vascular development using approaches not possible in other models. We therefore examined the effect of loss of function of PTHR1 or its ligand parathyroid hormone-related peptide (PTHrP) on aortic formation in zebrafish. APPROACH AND
RESULTS: Morpholino antisense oligonucleotide knockdown of either PTHR1 or PTHrP led to a localized occlusion of the mid-aorta in developing zebrafish. Confocal imaging of transgenic embryos showed that these defects were caused by loss of endothelium, rather than failure to lumenize. Using a Notch reporter transgenic ([CSL:Venus]qmc61), we found both PTHR1 and PTHrP knockdown-induced defective Notch signaling in the hypochord at the site of the aortic defect before onset of circulation, and the aortic occlusion was rescued by inducible Notch upregulation.
CONCLUSIONS: Loss of function of either PTHR1 or PTHrP leads to a localized aortic defect that is Notch dependent. These findings may underlie the aortic defect seen in Blomstrand chondrodysplasia, and reveal a link between parathyroid hormone and Notch signaling during aortic development.

Entities:  

Keywords:  angiogenesis; aortic coarctation; parathyroid hormone; zebrafish

Mesh:

Substances:

Year:  2013        PMID: 23559631     DOI: 10.1161/ATVBAHA.112.300590

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  6 in total

1.  PTH/PTHrP Receptor Signaling Restricts Arterial Fibrosis in Diabetic LDLR-/- Mice by Inhibiting Myocardin-Related Transcription Factor Relays.

Authors:  Abraham Behrmann; Dalian Zhong; Li Li; Su-Li Cheng; Megan Mead; Bindu Ramachandran; Parastoo Sabaeifard; Mohammad Goodarzi; Andrew Lemoff; Henry M Kronenberg; Dwight A Towler
Journal:  Circ Res       Date:  2020-03-11       Impact factor: 17.367

Review 2.  The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury.

Authors:  Virender K Rehan; John S Torday
Journal:  Antioxid Redox Signal       Date:  2014-03-12       Impact factor: 8.401

Review 3.  Coronary Microvascular Function and Beyond: The Crosstalk between Hormones, Cytokines, and Neurotransmitters.

Authors:  Carlo Dal Lin; Francesco Tona; Elena Osto
Journal:  Int J Endocrinol       Date:  2015-06-01       Impact factor: 3.257

4.  tmem33 is essential for VEGF-mediated endothelial calcium oscillations and angiogenesis.

Authors:  Aaron M Savage; Sathishkumar Kurusamy; Yan Chen; Zhen Jiang; Karishma Chhabria; Ryan B MacDonald; Hyejeong R Kim; Heather L Wilson; Fredericus J M van Eeden; Angel L Armesilla; Timothy J A Chico; Robert N Wilkinson
Journal:  Nat Commun       Date:  2019-02-13       Impact factor: 14.919

5.  Pthlha and mechanical force control early patterning of growth zones in the zebrafish craniofacial skeleton.

Authors:  Diego J Hoyle; Daniel B Dranow; Thomas F Schilling
Journal:  Development       Date:  2022-01-20       Impact factor: 6.868

6.  A gene trap transposon eliminates haematopoietic expression of zebrafish Gfi1aa, but does not interfere with haematopoiesis.

Authors:  Roshana Thambyrajah; Deniz Ucanok; Maryam Jalali; Yasmin Hough; Robert Neil Wilkinson; Kathryn McMahon; Chris Moore; Martin Gering
Journal:  Dev Biol       Date:  2016-07-16       Impact factor: 3.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.